Françoise Astorg Bollack

Greg Blackman Joins Opus 2 As CEO To Accelerate Global Growth

Retrieved on: 
Wednesday, December 6, 2023
Opus, Growth, Françoise Astorg Bollack, Workflow, Acquisition, Organization, SAP, Op. 2, Region, Management, Creative industries

LONDON, Dec. 6, 2023 /PRNewswire-PRWeb/ -- Today, leading legal software and services provider Opus 2 announced the hiring of Greg Blackman as chief executive officer. Blackman brings more than 25 years of executive leadership experience driving growth in enterprise software and services organizations.

Key Points: 
  • Blackman brings more than 25 years of executive leadership experience driving growth in enterprise software and services organizations.
  • "Opus 2 clients are uniquely driven, creative, and innovative in their use of technology," said Greg Blackman, the company's new CEO.
  • Previously, Blackman was Regional Vice President at SAP responsible for global revenue growth of subscription software, services, and support across all product lines.
  • "We are excited to have Greg Blackman join Opus 2 as CEO.

Ardian innovates with pioneering semiconductor investment platform

Retrieved on: 
Thursday, October 19, 2023
Identification, Partner, CVC, Semiconductor, NXP Semiconductors, KLA, European Chips Act, Rothschild, Financial Oversight and Management Board for Puerto Rico, Acquisition, Cypress Semiconductor, Senior, STMicroelectronics, Artificial intelligence, Bain Capital, IBM Microelectronics, Rothschild & Co, Atmel, Marketing, Partnership, Cloud computing, Françoise Astorg Bollack, Electronics, Culture, Lazard, IP, Automation, Fraunhofer Society, Renewable energy, Management, Infineon Technologies

Pioneering private equity investment platform dedicated to the semiconductor industry that will invest across the value chain focusing on Europe, with a unique approach combining Ardian's expertise and world-class semiconductor leaders.

Key Points: 
  • Pioneering private equity investment platform dedicated to the semiconductor industry that will invest across the value chain focusing on Europe, with a unique approach combining Ardian's expertise and world-class semiconductor leaders.
  • PARIS, Oct. 19, 2023 /CNW/ - Ardian , a world-leading private investment house, today announces that it is expanding into semiconductor investment with the launch of Ardian Semiconductor.
  • Ardian Semiconductor will be powered by a detailed analysis of technology megatrends and their implications across the semiconductor value chain.
  • It's therefore the perfect time to launch Ardian Semiconductor, leveraging Europe's leading positions in critical segments of the semiconductor value chain.

Fastmarkets appoints Larry Neal as Board Member

Retrieved on: 
Tuesday, August 1, 2023
IBM, General Electric, Profit and Loss, Lexipol, Françoise Astorg Bollack, Growth, Management

LONDON, Aug. 1, 2023 /PRNewswire/ -- Fastmarkets, a leading international price reporting agency providing pricing data, analysis and events to the global cross-commodity markets, is pleased to announce that Larry Neal has been appointed as a new member of its Board of Directors.

Key Points: 
  • LONDON, Aug. 1, 2023 /PRNewswire/ -- Fastmarkets, a leading international price reporting agency providing pricing data, analysis and events to the global cross-commodity markets, is pleased to announce that Larry Neal has been appointed as a new member of its Board of Directors.
  • This addition to the board further strengthens Fastmarkets' leadership and positions the company for continued growth and success.
  • Raju Daswani, CEO of Fastmarkets, said: "We are thrilled to welcome Larry to our Board of Directors.
  • James Davis, Partner at Astorg, the private equity firm backing Fastmarkets, said: "We are excited to have Larry Neal join the Board of Directors at Fastmarkets.

Fastmarkets demerges from Delinian

Retrieved on: 
Thursday, June 1, 2023
Growth, PRA, Risk management, Acquisition, Metal, Mining, Institutional investor, Cryptocurrency, Françoise Astorg Bollack

LONDON, June 1, 2023 /PRNewswire/ -- Fastmarkets today announces that it has completed the planned demerger from Delinian, formerly known as Euromoney Institutional Investor plc.

Key Points: 
  • LONDON, June 1, 2023 /PRNewswire/ -- Fastmarkets today announces that it has completed the planned demerger from Delinian, formerly known as Euromoney Institutional Investor plc.
  • As part of the transaction, Fastmarkets is now backed by private equity firm, Astorg.
  • Fastmarkets is the industry-leading price reporting agency (PRA) serving the metals, mining, forest products, energy transition and agriculture markets with over 10,000 customers globally.
  • Raju Daswani, CEO of Fastmarkets, said: "This is an exciting time for Fastmarkets given our position at the forefront of new energy transition-related markets.

BenevolentAI Unaudited Preliminary Results for the Year Ended 31 December 2022

Retrieved on: 
Thursday, March 16, 2023
Biotechnology, Pharmaceutical, Finance, Health, Artificial Intelligence, Health Technology, Professional Services, Technology, Knowledge, NLP, Medicines and Healthcare products Regulatory Agency, Drug discovery, Baricitinib, Euronext Amsterdam, IPF, CTA, AstraZeneca, CKD, Business analyst, Benevolence, Completeness, Google Knowledge Graph, MHRA, Chronic kidney disease, COVID-19, FDA, Idiopathic pulmonary fibrosis, Eli Lilly, BAI, Françoise Astorg Bollack, Natural language processing, Patent, IND, Medical device, Management, Pharmaceutical industry, Cryptocurrency, Sanofi

BenevolentAI (“BenevolentAI” or the “Company” or the “Group”) (Euronext Amsterdam: BAI), a leading, clinical-stage AI-enabled drug discovery and development company, announces its unaudited preliminary results for the year ended 31 December 2022.

Key Points: 
  • BenevolentAI (“BenevolentAI” or the “Company” or the “Group”) (Euronext Amsterdam: BAI), a leading, clinical-stage AI-enabled drug discovery and development company, announces its unaudited preliminary results for the year ended 31 December 2022.
  • Joanna Shields, Chief Executive Officer of BenevolentAI, said:
    “With the world’s attention on AI applications that deliver real-world impact, our progress in 2022 strongly positions BenevolentAI to capitalise on this moment.
  • Our AI platform is proven to enhance drug discovery, as demonstrated by our growing pipeline and successful collaboration with AstraZeneca.
  • Net cash, cash equivalents and short-term deposits position of £130.2 million as of 31 December 2022 at the top end of market guidance (2021: £40.6m)
    Maintained cash runway to Q4 2024, despite inflationary headwinds

Euromoney Institutional Investor PLC (the "Group" or "Euromoney") rebrands as Delinian Limited ("Delinian")

Retrieved on: 
Monday, January 23, 2023
Information services, Françoise Astorg Bollack, Epiry, Euromoney

Today Euromoney announces that it is rebranding as Delinian.

Key Points: 
  • Today Euromoney announces that it is rebranding as Delinian.
  • Delinian consists of Euromoney's specialist brands serving the financial and professional services and asset management industries.
  • Delinian is a vibrant portfolio of 20 information services businesses providing critical industry information to customers in over 140 countries.
  • Henry Elkington, Chairman-designate of Delinian, commented: "Delinian comprises a portfolio of trusted, specialist brands, deeply embedded in the markets they serve.

Euromoney Institutional Investor PLC (the "Group" or "Euromoney") rebrands as Delinian Limited ("Delinian")

Retrieved on: 
Monday, January 23, 2023
Information services, Françoise Astorg Bollack, Epiry, Euromoney

Today Euromoney announces that it is rebranding as Delinian.

Key Points: 
  • Today Euromoney announces that it is rebranding as Delinian.
  • Delinian consists of Euromoney's specialist brands serving the financial and professional services and asset management industries.
  • Delinian is a vibrant portfolio of 20 information services businesses providing critical industry information to customers in over 140 countries.
  • Henry Elkington, Chairman-designate of Delinian, commented: "Delinian comprises a portfolio of trusted, specialist brands, deeply embedded in the markets they serve.

HEC Paris-DowJones 2022 Large Buyout Performance Rankings show a stronger presence of European firms in the global top 20

Retrieved on: 
Wednesday, February 8, 2023
Investment, Blue Book Top 20 Network Rankings, General partnership, Permira, Veritas Capital, HEC Paris, Partnership, Observation, GP, Waterland, TA Associates, Francisco Partners, Preqin, Clayton, Dubilier & Rice, Vitruvian Partners, Paris, Satellite navigation device, Françoise Astorg Bollack, EU, European

HEC Paris Business School and DowJones have released the results of this year’s Large Buyout Performance Rankings, which show the top 20 private equity firms based on all buyout funds raised between 2009 and 2018.

Key Points: 
  • HEC Paris Business School and DowJones have released the results of this year’s Large Buyout Performance Rankings, which show the top 20 private equity firms based on all buyout funds raised between 2009 and 2018.
  • The top three companies in the Top 20 global firms are TA Associates, followed by Veritas Capital and Francisco Partners.
  • Other firms making the Global Top 20 include Vitruvian Partners and Permira, both based in London, and Astorg, based in France.
  • The study gathered performance data, as of December 2022, from Preqin or from data directly provided to HEC Paris for the purpose of the rankings.

OPEN Health Appoints David P. King as Non-Executive Chairman and Paul Carter as Independent Board Member

Retrieved on: 
Monday, November 28, 2022
Software, Growth, Science, LabCorp, Head, Health, Multimedia, Hospital, Knowledge, Partnership, Patient, OPEN, Medicine, Acquisition, Management, Fine chemical, Pharmaceutical industry, Françoise Astorg Bollack

OPEN Health's strong customer relationships and deep commitment to science position it well for continued growth.

Key Points: 
  • OPEN Health's strong customer relationships and deep commitment to science position it well for continued growth.
  • I look forward to working with OPEN Health's market-leading management team as they continue to provide innovative solutions to positively impact science, medicine, and patients' lives," remarked David.
  • "We are delighted to welcome Dave and Paul to the OPEN Health board of directors, both stalwarts in the pharma ecosystem," Rob Barker, OPEN Health CEO, said.
  • OPEN Health unites deep scientific knowledge with wide-ranging specialist expertise to unlock possibilities that improve health outcomes and patient well-being.

OPEN Health Appoints David P. King as Non-Executive Chairman and Paul Carter as Independent Board Member

Retrieved on: 
Monday, November 28, 2022
Software, Growth, Science, LabCorp, Head, Health, Hospital, Knowledge, Partnership, Patient, OPEN, Medicine, Acquisition, Management, Fine chemical, Pharmaceutical industry, Françoise Astorg Bollack

David P. King will be able to draw on his extensive experience within the pharma services industry to support OPEN Health's continued growth and expansion.

Key Points: 
  • David P. King will be able to draw on his extensive experience within the pharma services industry to support OPEN Health's continued growth and expansion.
  • OPEN Health's strong customer relationships and deep commitment to science position it well for continued growth.
  • "We are delighted to welcome Dave and Paul to the OPEN Health board of directors, both stalwarts in the pharma ecosystem," Rob Barker, OPEN Health CEO, said.
  • OPEN Health unites deep scientific knowledge with wide-ranging specialist expertise to unlock possibilities that improve health outcomes and patient well-being.